Comparison of Apidra to Regular Insulin in Hospitalized Patients

Completed · Not applicable

Conditions studied: Diabetes Mellitus, Type II

In brief

The purpose of this study is to compare Apidra (a rapid acting insulin analogue) with Regular insulin (fast acting) in addition to the use of long acting insulin Glargine in hospitalized patients in terms of efficacy and safety in blood glucose control and frequency of low blood glucose. Blood glucose control along with incidence and rate of low blood glucose during the hospitalization shall be of primary interest; length of hospital stay comparing the short acting insulin used shall be the secondary interest.

Key facts

Study ID

NCT00528918

Run by

Carl T. Hayden VA Medical Center

People needed

300

Starts

2007-06-01

Expected to finish

2011-05-01

Last updated by the study team

2014-07-24

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects must be admitted to non-critical care units with expected length of stay of at least three days.
• Subjects must be able to communicate meaningfully with the investigator and must be legally competent to provide written informed consent.
• Subjects may be of either sex. Female subjects of child-bearing potential must be non-lactating and have a negative pregnancy test before starting the study.
• Subjects must be diagnosed with T2DM or develop hyperglycemia (BG >180 mg/dl) during hospitalization.

You may not qualify if…

• Subjects must not be admitted for 'observation' or for expected length of stay of less than three days.
• Subjects must not have Type 1 Diabetes.
• Subjects must not be using rapid acting insulin analogues.
• Subjects must not be receiving nutrition via tube feedings.

Where it is running

• Phoenix VA Health Care System — Phoenix, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.